Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas

Autor: Mortensen, A.C.L., Imgenberg-Kreuz, J., Spiegelberg, D., Botling, J., Nestor, M.
Zdroj: In Heliyon December 2023 9(12)
Databáze: ScienceDirect